In the last trading session, 2.2 million Kazia Therapeutics Limited ADR (NASDAQ:KZIA) shares changed hands as the company’s beta touched 2.12. With the company’s per share price at $1.58 changed hands at -$0.32 or -16.84% during last session, the market valuation stood at $5.26M. KZIA’s last price was a discount, traded about -900.0% off its 52-week high of $15.80. The share price had its 52-week low at $1.32, which suggests the last value was 16.46% up since then. When we look at Kazia Therapeutics Limited ADR’s average trading volume, we note the 10-day average is 10.67 million shares, with the 3-month average coming to 1.80 million.
Analysts gave the Kazia Therapeutics Limited ADR (KZIA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended KZIA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Kazia Therapeutics Limited ADR’s EPS for the current quarter is expected to be 0.
Kazia Therapeutics Limited ADR (NASDAQ:KZIA) trade information
Instantly KZIA was in red as seen at the end of in last trading. With action -7.06%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -10.73%, with the 5-day performance at -7.06% in the red. However, in the 30-day time frame, Kazia Therapeutics Limited ADR (NASDAQ:KZIA) is -49.03% down. Looking at the short shares, we see there were 18773.0 shares sold at short interest cover period of 0.11 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 11.47%.
KZIA Dividends
Kazia Therapeutics Limited ADR is expected to release its next quarterly earnings report in March.
Kazia Therapeutics Limited ADR (NASDAQ:KZIA)’s Major holders
The share float percentage for the stock currently stands at 7.06%. There are 7.06% institutions holding the Kazia Therapeutics Limited ADR stock share, with MORGAN STANLEY the top institutional holder. As of 2024-06-30, the company held 0.8386% of the shares, roughly 0.2 million KZIA shares worth $45967.0.
BNP PARIBAS ARBITRAGE, SNC holds the second largest percentage of outstanding shares, with 0.2651% or 63568.0 shares worth $14532.0 as of 2024-06-30.
With 1.48 shares estimated at $2335.0 under it, the former controlled 0.03% of total outstanding shares.
